MA42399A - Composés inhibiteurs de la voie de signalisation de notch - Google Patents
Composés inhibiteurs de la voie de signalisation de notchInfo
- Publication number
- MA42399A MA42399A MA042399A MA42399A MA42399A MA 42399 A MA42399 A MA 42399A MA 042399 A MA042399 A MA 042399A MA 42399 A MA42399 A MA 42399A MA 42399 A MA42399 A MA 42399A
- Authority
- MA
- Morocco
- Prior art keywords
- inhibitor compounds
- path inhibitor
- notch path
- notch
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562189393P | 2015-07-07 | 2015-07-07 | |
EP16741742.7A EP3319967B1 (fr) | 2015-07-07 | 2016-07-01 | Composés inhibiteurs de la voie de signalisation de notch |
PCT/US2016/040612 WO2017007702A1 (fr) | 2015-07-07 | 2016-07-01 | Composés inhibiteurs de la voie de signalisation de notch |
Publications (2)
Publication Number | Publication Date |
---|---|
MA42399A true MA42399A (fr) | 2018-05-16 |
MA42399B1 MA42399B1 (fr) | 2019-08-30 |
Family
ID=56507825
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA42399A MA42399B1 (fr) | 2015-07-07 | 2016-07-01 | Composés inhibiteurs de la voie de signalisation de notch |
Country Status (42)
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI625332B (zh) | 2015-07-07 | 2018-06-01 | 美國禮來大藥廠 | 刻痕(notch)路徑傳訊抑制化合物 |
WO2018005830A1 (fr) | 2016-06-29 | 2018-01-04 | Otonomy, Inc. | Formulations otiques à base de triglycérides et leurs utilisations |
US11253193B2 (en) * | 2016-11-08 | 2022-02-22 | Cochlear Limited | Utilization of vocal acoustic biomarkers for assistive listening device utilization |
KR20190098998A (ko) | 2016-12-16 | 2019-08-23 | 파이프라인 테라퓨틱스, 아이엔씨. | 달팽이관 시냅스질환의 치료 방법 |
JP2020511486A (ja) * | 2017-03-24 | 2020-04-16 | ノバルティス アーゲー | イソオキサゾールカルボキサミド化合物及びその使用 |
CN113227128B (zh) * | 2018-07-20 | 2024-06-21 | 香港理工大学 | 针对抑制jag1-notch1信号通路的肽 |
PE20211071A1 (es) * | 2018-09-21 | 2021-06-09 | Novartis Ag | Compuestos de isoxazol carboxamida y usos de los mismos |
CA3114113A1 (fr) | 2018-10-02 | 2020-04-09 | Frequency Therapeutics, Inc. | Compositions pharmaceutiques comprenant des agents therapeutiques otiques et procedes associes |
WO2020112883A1 (fr) * | 2018-11-30 | 2020-06-04 | Massachusetts Eye And Ear Infirmary | Inhibition de la lysine déméthylase 1 (lsd1), induisant la différenciation des cellules ciliées |
SG11202111191YA (en) | 2019-04-08 | 2021-11-29 | Frequency Therapeutics Inc | Combination of chir99021 and valproic acid for treating hearing loss |
US20230118097A1 (en) * | 2020-01-22 | 2023-04-20 | Beth Israel Deaconess Medical Center, Inc. | Biomarkers for placenta accreta spectrum (pas) disorders |
WO2023200017A1 (fr) * | 2022-04-11 | 2023-10-19 | Prism BioLab Co., Ltd. | Nouveaux composés à cycles fusionnés à sept éléments |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8673634B2 (en) | 2003-11-13 | 2014-03-18 | Massachusetts Eye & Ear Infirmary | Method for the treatment of hearing loss |
AU2007229550B2 (en) | 2006-03-27 | 2012-03-08 | F. Hoffmann-La Roche Ag | Malonamide derivatives as gamma secretase inhibitors |
EP2254572B1 (fr) | 2008-02-07 | 2013-10-16 | Massachusetts Eye & Ear Infirmary | Composés stimulant l expression du gène atoh-1 |
US8648119B2 (en) | 2008-05-23 | 2014-02-11 | Otonomy, Inc. | Controlled release immunomodulator compositions and methods for the treatment of otic disorders |
WO2010060088A2 (fr) | 2008-11-24 | 2010-05-27 | Massachusetts Eye & Ear Infirmary | Voies pour générer des cellules pileuses |
US9125894B2 (en) | 2010-10-06 | 2015-09-08 | Massachusetts Eye & Ear Infirmary | Methods for promoting reinnervation of auditory hair cells |
JO3148B1 (ar) * | 2011-07-27 | 2017-09-20 | Lilly Co Eli | مركب مثبط لإشارات مسار notch |
US8716229B2 (en) | 2011-11-09 | 2014-05-06 | Massachusetts Eye & Ear Infirmary | Osteoprotegerin in neuroprotection |
WO2014039781A1 (fr) * | 2012-09-07 | 2014-03-13 | Massachusetts Eye & Ear Infirmary | Traitement de la perte auditive |
CA2887642A1 (fr) | 2012-11-02 | 2014-05-08 | Genesys Research Institute | Compositions et methodes pour therapie auditive |
TWI625332B (zh) | 2015-07-07 | 2018-06-01 | 美國禮來大藥廠 | 刻痕(notch)路徑傳訊抑制化合物 |
KR20190098998A (ko) * | 2016-12-16 | 2019-08-23 | 파이프라인 테라퓨틱스, 아이엔씨. | 달팽이관 시냅스질환의 치료 방법 |
-
2016
- 2016-06-21 TW TW105119456A patent/TWI625332B/zh active
- 2016-06-21 AR ARP160101848A patent/AR105080A1/es active IP Right Grant
- 2016-06-21 JO JOP/2016/0125A patent/JO3491B1/ar active
- 2016-07-01 MX MX2017016555A patent/MX2017016555A/es active IP Right Grant
- 2016-07-01 MY MYPI2018700032A patent/MY197519A/en unknown
- 2016-07-01 MD MDE20180506 patent/MD3319967T2/ro unknown
- 2016-07-01 NZ NZ737322A patent/NZ737322A/en unknown
- 2016-07-01 DK DK16741742.7T patent/DK3319967T3/da active
- 2016-07-01 JP JP2017568395A patent/JP6571214B2/ja active Active
- 2016-07-01 ME MEP-2019-191A patent/ME03495B/fr unknown
- 2016-07-01 TR TR2019/08683T patent/TR201908683T4/tr unknown
- 2016-07-01 PE PE2018000012A patent/PE20180412A1/es unknown
- 2016-07-01 TN TNP/2017/000495A patent/TN2017000495A1/en unknown
- 2016-07-01 UA UAA201712094A patent/UA120539C2/uk unknown
- 2016-07-01 AU AU2016289822A patent/AU2016289822B2/en active Active
- 2016-07-01 PL PL16741742T patent/PL3319967T3/pl unknown
- 2016-07-01 EP EP16741742.7A patent/EP3319967B1/fr active Active
- 2016-07-01 US US15/736,345 patent/US10450317B2/en active Active
- 2016-07-01 MA MA42399A patent/MA42399B1/fr unknown
- 2016-07-01 CA CA2987431A patent/CA2987431C/fr active Active
- 2016-07-01 CN CN201680039699.XA patent/CN107849054B/zh active Active
- 2016-07-01 RS RS20190820A patent/RS59115B1/sr unknown
- 2016-07-01 ES ES16741742T patent/ES2735139T3/es active Active
- 2016-07-01 WO PCT/US2016/040612 patent/WO2017007702A1/fr active Application Filing
- 2016-07-01 SI SI201630270T patent/SI3319967T1/sl unknown
- 2016-07-01 EA EA201792478A patent/EA032634B1/ru not_active IP Right Cessation
- 2016-07-01 PT PT16741742T patent/PT3319967T/pt unknown
- 2016-07-01 LT LTEP16741742.7T patent/LT3319967T/lt unknown
- 2016-07-01 HU HUE16741742 patent/HUE044666T2/hu unknown
- 2016-07-01 CR CR20220368A patent/CR20220368A/es unknown
- 2016-07-01 KR KR1020187000149A patent/KR102078946B1/ko active IP Right Grant
- 2016-07-01 CR CR20170598A patent/CR20170598A/es unknown
-
2017
- 2017-11-16 IL IL255726A patent/IL255726B/en active IP Right Grant
- 2017-11-20 ZA ZA2017/07858A patent/ZA201707858B/en unknown
- 2017-12-20 SV SV2017005597A patent/SV2017005597A/es unknown
-
2018
- 2018-01-02 CL CL2018000007A patent/CL2018000007A1/es unknown
- 2018-01-02 EC ECIEPI201842A patent/ECSP18000042A/es unknown
- 2018-01-05 DO DO2018000005A patent/DOP2018000005A/es unknown
- 2018-01-05 PH PH12018500047A patent/PH12018500047A1/en unknown
- 2018-01-12 CO CONC2018/0000224A patent/CO2018000224A2/es unknown
- 2018-05-17 HK HK18106380.5A patent/HK1247187B/zh unknown
-
2019
- 2019-06-28 HR HRP20191175TT patent/HRP20191175T1/hr unknown
- 2019-07-23 CY CY20191100776T patent/CY1122024T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA42399A (fr) | Composés inhibiteurs de la voie de signalisation de notch | |
MA42293A (fr) | Composés antibactériens | |
DK3668855T3 (da) | Herbicide forbindelser | |
MA44050A (fr) | Nouveaux composés | |
DK3601283T3 (da) | Kondenseret imidazo-piperidin-JAK-inhibitorforbindelse | |
MA44233A (fr) | Nouveaux composés | |
MA47573A (fr) | Inhibiteurs de dihydrobenzofurane glycosidase substitués | |
MA53944A (fr) | Inhibiteurs de la glycosidase | |
MA41614A (fr) | Composés antiviraux | |
MA44474A (fr) | Nouveaux inhibiteurs de la ferroportine | |
MA46242A (fr) | Composés inhibiteurs de bêta-lactamase | |
MA41976A (fr) | Composition lubrifiante ultra-fluide | |
MA41127A (fr) | Chaussure auto-extensible | |
MA45221A (fr) | Nouveaux composés antibactériens | |
DK3612519T3 (da) | Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl forbindelser | |
MA43367A (fr) | Inhibiteurs de métallo-bêta-lactamases | |
FR3034100B1 (fr) | Composition lubrifiante | |
DK3571192T3 (da) | Jak1-selektive inhibitorer | |
BR112017017193A2 (pt) | compostos herbicidas | |
MA46280A (fr) | Inhibiteurs de la dopamine-b-hydroxylase | |
DK3630744T3 (da) | Pyrazol-magl-inhibitorer | |
BR112017002508A2 (pt) | novos compostos substituídos com halogênio | |
MA50504A (fr) | Composés antibactériens | |
MA49522A (fr) | Nouveaux composés de quinoléinone | |
MA43275A (fr) | Composé de pyranodipyridine |